A new treatment for septic patients

Alteco Medical

Alteco Medical develops a unique medical device offering a completely new technology for intensive care of the septic patient. A product that selectively adsorbs endotoxin from whole blood for a successful treatment of patients with sepsis.

Alteco Medical

CEO:

Håkan Petersson

First investment year:

2012

Business sector:

Life Science, Medtech

Investment manager: Tor Kihlberg Visit website